• Resize Text
    • Small Text
    • Medium Text
    • Large Text
    • Connect
Central Nervous System
Central Nervous System

Lyflex Oral Solution (Baclofen)

Baclofen is in a class of medications called skeletal muscle relaxants.

Baclofen is indicated for:

The relief of voluntary muscle spasticity resulting from disorders such as: multiple sclerosis, other spinal lesions, e.g. tumours of the spinal cord, syringomyelia, motor neurone disease, transverse myelitis, traumatic partial section of the cord.

In adults and children for the relief of spasticity of voluntary muscle arising from e.g. cerebrovascular accidents, cerebral palsy, meningitis, traumatic head injury.

Paediatric population

Baclofen is indicated in patients 0 to <18 years for the symptomatic treatment of spasticity of cerebral origin, especially where due to infantile cerebral palsy, as well as following cerebrovascular accidents or in the presence of neoplastic or degenerative brain disease.

Baclofen is also indicated for the symptomatic treatment of muscle spasms occurring in spinal cord diseases of infectious, degenerative, traumatic, neoplastic, or unknown origin such as multiple sclerosis, spastic spinal paralysis, amyotrophic lateral sclerosis, syringomyelia, transverse myelitis, traumatic paraplegia or paraparesis, and compression of the spinal cord.

Icon respresenting a network

Summary of Product Characteristics

Read this summary of product characteristics for further information about Baclofen Oral Solution. Click below to navigate to the EMC.

More info
Icon respresenting a person

Patient Information Leaflet

Read this patient information leaflet about Baclofen Oral Solution, what it’s used for and possible side effects. Click below to navigate to the EMC.

More info
Central Nervous System

Lyflex Oral Solution (Baclofen)

Lyflex Oral Solution (Baclofen)
Click here for Audio Version
Flavour Raspberry
Storage Conditions Do not store above 25°C. Store in the original container. Do not refrigerate or freeze.
Sucrose Free
Shelf Life (Closed Bottle/Open Bottle) 2 years/56 days
PIP Code 3086311
EAN Code 5016119000867
Sodium Levels Essentially sodium-free at doses less than 30ml . At maximum daily dose (100 ml) this medicine contains 77 mg of sodium
Ethanol Concentration None


Adverse Drug Events

Information about adverse event reporting can be found at www.mhra.gov.uk/yellowcard
Adverse events should also be reported to Rosemont Pharmaceuticals Ltd on 0113 244 1400

Rosemont Pharmaceuticals - World Map icon

Contact us

For further product information and pricing please use the form below and a member of the team will be in touch

    Please prove you are human by selecting the Key.

    Stay updated via our App


    A new Rosemont Pharmaceuticals App for Healthcare Professionals is launching soon.

    Rosemont app on a mobile device

    Central Nervous System

    Lyflex Oral Solution (Baclofen)

    Lyflex Oral Solution (Baclofen)